Barra, Maria J. https://orcid.org/0000-0002-7195-5133
Wilkinson, Alexis F.
Ma, Ariel E.
Goli, Karthik
Atif, Hira
Osman, Nafissa M.R.B.
Lorenzoni, Cesaltina
Tivir, Guilhermina
Lathrop, Eva H.
Castle, Philip E.
Guo, Ming
Montealegre, Jane R.
Baker, Ellen S.
Salcedo, Mila P.
Schmeler, Kathleen M.
Richards-Kortum, Rebecca R. https://orcid.org/0000-0003-2347-9467
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA292741, P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (U54EB034652)
UT | University of Texas MD Anderson Cancer Center (128997)
Article History
Received: 18 February 2025
Accepted: 22 July 2025
First Online: 7 August 2025
Competing interests
: P.E.C. has received HPV tests and assays from Cepheid and Atila Biosystems at no or reduced cost for research purposes only. The remaining authors declare no competing interests.